Analysis of the peripheral blood lymphocyte subsets in patients with bladder carcinoma

Urology

Volumn 53, Issue 1, 1999, Pages 88-91

  Soygür, Tarkan ^a   Bedük, Yaşar ^a   Yaman, Önder ^a   Yilmaz, Erdal ^a   Tokgöz, Güner ^a   Göǧüş, Orhan ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER IMMUNOLOGY; CANCER INVASION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; URINARY BLADDER NEOPLASMS;

EID: 0032907643     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00447-6     Document Type: Article

References (15)

1. Chretien P.B., Crowder W.L., Gertner H.R., et al. Correlation of preoperative lymphocyte reactivity with the clinical course of cancer patients. Surg Gynecol Abd Obstet. 136:1973;380-384.
2. Fujibayashi K., Sato O., Ito H. Stage related cell-mediated cytotoxicity with effector cell analysis and computation on cytotoxic activity of T cells and non-T cells. Cell Immunol. 44:1979;225-241.
3. Babaian R.J., Watson D.A., Jones J.M. Immune complexes in urine and serum of patients with bladder cancer. J Urol. 131:1984;463-468.
4. Bubenik J., Perlman P., Helmstein K., et al. Immune response to urinary tumors in man. Int J Cancer. 5:1970;39-46.
5. O'Toole C., Perlman P., Unsgaard B., et al. Cellular immunity to human urinary bladder carcinoma. Correlation to clinical stage and radiotherapy. Int J Cancer. 10:1972;77-91.
6. Shaw M., Ray P., Rubenstein M., et al. Lymphocyte subsets in urologic cancer patients. Urol Res. 15:1987;181-185.
7. Tsujihaji H., Uejima S., Akiyama T., et al. Immunohistochemical detection of tissue infiltrating lymphocytes in bladder tumors. Urol Int. 44:1989;5-9.
8. Greenstein A., Pecht M., Kaver I., et al. Characterization of peripheral blood T cell subpopulation of bladder cancer patients. Urol Res. 19:1991;219-222.
9. Kaver I., Pecht M., Trainin N., et al. T lymphocyte subsets and function in peripheral blood of patients with urological cancer. Oncology. 49:1992;108-113.
10. Ma C.P., Yu D.S., Yeh M.Y., et al. Natural killer cell activity in patients with urologic cancer. Eur Urol. 13:1987;397-400.
11. Carballido J., Alvarez-Mon M., Solovera J., et al. Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder. J Urol. 143:1990;29-33.
12. Morales A., Facs F., Ottenhof P.C. Clinical application of a whole blood assay for human natural killer (NK) cell activity. Cancer. 52:1983;667-670.
13. Britten V., Rees C.G., Clegg A., et al. Natural killer cell activity and response to phytohaemaglutinin compared with the histological diagnosis of patients with transitional cell carcinoma of the bladder. Br J Urol. 54:1982;261-266.
14. Steinhauer E.H., Doyle A.T., Reed J., et al. Defective natural cytoxicity in patients with cancer normal number of effector cells but decreased recycling capacity in patients with advanced disease . J Immunol. 129:1982;2225-2233.
15. Yaman Ö., Baltaci S., Arikan N., et al. Staging with computed tomography, transrectal ultrasonography and transurethral resection of bladder tumor comparison with final pathological stage in invasive bladder carcinoma . Br J Urol. 78:1996;197-200.